CAREDX, INC. Proceeds from (Repayments of) Bank Overdrafts
CAREDX, INC. (CDNA) reported Proceeds from (Repayments of) Bank Overdrafts of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfBankOverdrafts · last filed 2020-02-28
- CAREDX, INC. proceeds from (repayments of) bank overdrafts for the quarter ending 2017-12-31 was -$518.00K.
- CAREDX, INC. proceeds from (repayments of) bank overdrafts for the quarter ending 2017-09-30 was $405.00K, a 106.63% increase year-over-year.
- CAREDX, INC. proceeds from (repayments of) bank overdrafts for the quarter ending 2016-12-31 was $0.00.
- CAREDX, INC. proceeds from (repayments of) bank overdrafts for the quarter ending 2016-09-30 was $196.00K.
- CAREDX, INC. proceeds from (repayments of) bank overdrafts for fiscal 2019 was $0.00.
- CAREDX, INC. proceeds from (repayments of) bank overdrafts for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- CAREDX, INC. proceeds from (repayments of) bank overdrafts for fiscal 2017 was $63.00K.
- CAREDX, INC. proceeds from (repayments of) bank overdrafts for fiscal 2016 was $0.00.
| Period end | Proceeds from (Repayments of) Bank Overdrafts 3 month | Proceeds from (Repayments of) Bank Overdrafts 6 month | Proceeds from (Repayments of) Bank Overdrafts 9 month | Proceeds from (Repayments of) Bank Overdrafts 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-28 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-02-28 | |||
| 2017-12-31 | -$518.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$113.00K derived: sum of 2 quarters · filed 2020-02-28 | $63.00K 10-K · filed 2020-02-28 | |
| 2017-09-30 | $405.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $581.00K 10-Q · filed 2017-11-09 | ||
| 2017-06-30 | $176.00K 10-Q · filed 2017-08-11 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $196.00K derived: sum of 2 quarters · filed 2019-03-06 | $0.00 10-K · filed 2019-03-06 | |
| 2016-09-30 | $196.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | -$196.00K 10-Q · filed 2017-08-11 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |